PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32627023-0	2020	In vitro demonstration of salinomycin as a novel chemotherapeutic agent for the treatment of SOX2-positive glioblastoma cancer stem cells.	salinomycin	26-37	SRY-box transcription factor 2	Homo sapiens	93-97	
32627023-7	2020	It was revealed that salinomycin decreased the expression of the GSC marker SOX2 at both the transcriptional and translational level.	salinomycin	21-32	SRY-box transcription factor 2	Homo sapiens	76-80	
22511343-9	2012	Treatment of mammospheres with salinomycin reduced the expression of SOX2 indicating a selective targeting of cancer stem cells.	salinomycin	31-42	SRY-box transcription factor 2	Homo sapiens	69-73	
26407842-5	2015	Mammosphere formation assays revealed that salinomycin suppresses self-renewal of ALDH1-positive BCSCs and downregulates the transcription factors Nanog, Oct4 and Sox2.	salinomycin	43-54	SRY-box transcription factor 2	Homo sapiens	163-167	
21222617-6	2011	Expression of stem cell markers OCT-4, NANOG and SOX2 in ALDH positive A549 lung cells was decreased significantly by real-time RT-PCR analysis after 24 hour salinomycin treatment.	salinomycin	158-169	SRY-box transcription factor 2	Homo sapiens	49-53